Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy
View ORCID ProfileDimitrios C. Mastellos, Bruno G. P. Pires da Silva, Benedito A. L. Fonseca, Natasha P. Fonseca, Maria A. Martins, Sara Mastaglio, Annalisa Ruggeri, Marina Sironi, Peter Radermacher, View ORCID ProfilePanagiotis Skendros, View ORCID ProfileKonstantinos Ritis, Ilenia Manfra, Simona Iacobelli, Markus Huber-Lang, Bo Nilsson, Despina Yancopoulou, View ORCID ProfileE. Sander Connolly, View ORCID ProfileCecilia Garlanda, View ORCID ProfileFabio Ciceri, Antonio M. Risitano, View ORCID ProfileRodrigo T. Calado, View ORCID ProfileJohn D. Lambris
doi: https://doi.org/10.1101/2020.08.17.20174474
Dimitrios C. Mastellos
1National Center for Scientific Research ‘Demokritos’, Aghia Paraskevi, Athens, Greece
Bruno G. P. Pires da Silva
2Department of Medical Imaging, Hematology and Clinical Oncology, University of São Paulo, Ribeirão Preto School of Medicine, Brazil
Benedito A. L. Fonseca
3Department of Internal Medicine, University of São Paulo, Ribeirão Preto School of Medicine, Brazil
Natasha P. Fonseca
2Department of Medical Imaging, Hematology and Clinical Oncology, University of São Paulo, Ribeirão Preto School of Medicine, Brazil
Maria A. Martins
4Intensive Care Unit, University Hospital, University of São Paulo, Ribeirão Preto School of Medicine, Brazil
Sara Mastaglio
5Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
Annalisa Ruggeri
5Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
Marina Sironi
6Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy
Peter Radermacher
7Sektion Anästhesiologische Pathophysiologie und Verfahrensentwicklung, University Hospital of Ulm, Ulm, Germany
Panagiotis Skendros
8First Department of Internal Medicine and Laboratory of Molecular Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece
Konstantinos Ritis
8First Department of Internal Medicine and Laboratory of Molecular Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece
Ilenia Manfra
9AORN San Giuseppe Moscati, Hematology and Hematopoietic Stem Cell Transplantation Unit, Avellino, Italy
Simona Iacobelli
10Department of Biology, University of Rome Tor Vergata, Rome, Italy
Markus Huber-Lang
11Institute for Clinical and Experimental Trauma-Immunology, University Hospital of Ulm, Ulm, Germany
Bo Nilsson
12Division of Clinical Immunology, Uppsala University Hospital, Uppsala, Sweden
Despina Yancopoulou
13Amyndas Pharmaceuticals, Glyfada, Greece
E. Sander Connolly
14Department of Neurological Surgery, Columbia University, New York, NY, USA
Cecilia Garlanda
6Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy
15Humanitas University, Pieve Emanuele, Milan, Italy
Fabio Ciceri
5Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
16University Vita Salute San Raffaele, Milan, Italy
Antonio M. Risitano
9AORN San Giuseppe Moscati, Hematology and Hematopoietic Stem Cell Transplantation Unit, Avellino, Italy
17Federico II University of Naples, Naples, Italy
Rodrigo T. Calado
2Department of Medical Imaging, Hematology and Clinical Oncology, University of São Paulo, Ribeirão Preto School of Medicine, Brazil
John D. Lambris
18Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Article usage
Posted August 21, 2020.
Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy
Dimitrios C. Mastellos, Bruno G. P. Pires da Silva, Benedito A. L. Fonseca, Natasha P. Fonseca, Maria A. Martins, Sara Mastaglio, Annalisa Ruggeri, Marina Sironi, Peter Radermacher, Panagiotis Skendros, Konstantinos Ritis, Ilenia Manfra, Simona Iacobelli, Markus Huber-Lang, Bo Nilsson, Despina Yancopoulou, E. Sander Connolly, Cecilia Garlanda, Fabio Ciceri, Antonio M. Risitano, Rodrigo T. Calado, John D. Lambris
medRxiv 2020.08.17.20174474; doi: https://doi.org/10.1101/2020.08.17.20174474
Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy
Dimitrios C. Mastellos, Bruno G. P. Pires da Silva, Benedito A. L. Fonseca, Natasha P. Fonseca, Maria A. Martins, Sara Mastaglio, Annalisa Ruggeri, Marina Sironi, Peter Radermacher, Panagiotis Skendros, Konstantinos Ritis, Ilenia Manfra, Simona Iacobelli, Markus Huber-Lang, Bo Nilsson, Despina Yancopoulou, E. Sander Connolly, Cecilia Garlanda, Fabio Ciceri, Antonio M. Risitano, Rodrigo T. Calado, John D. Lambris
medRxiv 2020.08.17.20174474; doi: https://doi.org/10.1101/2020.08.17.20174474
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2694)
- Dermatology (229)
- Emergency Medicine (405)
- Epidemiology (12333)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4170)
- Geriatric Medicine (393)
- Health Economics (689)
- Health Informatics (2703)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3954)
- Nursing (214)
- Nutrition (587)
- Oncology (2084)
- Ophthalmology (596)
- Orthopedics (245)
- Otolaryngology (308)
- Pain Medicine (254)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1134)
- Primary Care Research (462)
- Public and Global Health (6593)
- Radiology and Imaging (1430)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (345)
- Surgery (456)
- Toxicology (56)
- Transplantation (191)
- Urology (170)